|
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with …
PR Newswire (press release) Boehringer Ingelheim announced that a comprehensive confirmatory Phase III trial program named UniTinA-asthma™ is ongoing to fully evaluate the potential of the long-acting bronchodilator in the treatment of asthma in pediatric, adolescent and adult … Promising Phase II Data With Once-Daily Tiotropium may Lead to New Treatment … Results of Phase II Study of Boehringer Ingelheim's Investigational … |
View full post on asthma – Google News